JP2004500829A - 新規な脂質結合タンパク質４ - Google Patents

新規な脂質結合タンパク質４ Download PDF

Info

Publication number
JP2004500829A
JP2004500829A JP2001576864A JP2001576864A JP2004500829A JP 2004500829 A JP2004500829 A JP 2004500829A JP 2001576864 A JP2001576864 A JP 2001576864A JP 2001576864 A JP2001576864 A JP 2001576864A JP 2004500829 A JP2004500829 A JP 2004500829A
Authority
JP
Japan
Prior art keywords
polypeptide
seq
polynucleotide
sequence
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001576864A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004500829A5 (enExample
Inventor
グレル、　マティアス
デュエッケル、　クラウス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JP2004500829A publication Critical patent/JP2004500829A/ja
Publication of JP2004500829A5 publication Critical patent/JP2004500829A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001576864A 2000-04-18 2001-04-11 新規な脂質結合タンパク質４ Pending JP2004500829A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00107995 2000-04-18
PCT/EP2001/004170 WO2001079269A2 (en) 2000-04-18 2001-04-11 Lipid binding protein 4

Publications (2)

Publication Number Publication Date
JP2004500829A true JP2004500829A (ja) 2004-01-15
JP2004500829A5 JP2004500829A5 (enExample) 2005-01-27

Family

ID=8168455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001576864A Pending JP2004500829A (ja) 2000-04-18 2001-04-11 新規な脂質結合タンパク質４

Country Status (5)

Country Link
US (1) US6924357B2 (enExample)
EP (1) EP1274842A2 (enExample)
JP (1) JP2004500829A (enExample)
CA (1) CA2406195A1 (enExample)
WO (1) WO2001079269A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016508036A (ja) * 2012-12-28 2016-03-17 アンニバレ・アレッサンドロ・プカ Ｂｐｉｆｂ４タンパク質の変異体
JP2020531047A (ja) * 2017-08-16 2020-11-05 エッレジヴ１・ソチエタ・ア・レスポンサビリタ・リミタータ 神経疾患及び神経損傷における使用のためのｂｐｉｆｂ４タンパク質のｖｔｆｔアイソフォーム

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406066A1 (en) * 2000-04-18 2001-10-25 Merck Patent Gesellschaft Mit Beschraenkter Haftung Lipid binding protein 3

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016508036A (ja) * 2012-12-28 2016-03-17 アンニバレ・アレッサンドロ・プカ Ｂｐｉｆｂ４タンパク質の変異体
JP2020531047A (ja) * 2017-08-16 2020-11-05 エッレジヴ１・ソチエタ・ア・レスポンサビリタ・リミタータ 神経疾患及び神経損傷における使用のためのｂｐｉｆｂ４タンパク質のｖｔｆｔアイソフォーム

Also Published As

Publication number Publication date
WO2001079269A3 (en) 2002-03-07
US20030124582A1 (en) 2003-07-03
US6924357B2 (en) 2005-08-02
WO2001079269A2 (en) 2001-10-25
CA2406195A1 (en) 2001-10-25
EP1274842A2 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
JP2004504061A (ja) ＥｐｈＡ受容体ファミリーの新規メンバー
JP2003531611A (ja) ナトリウム−カリウム交換体タンパク質
JP2003528608A (ja) ヒトｇａｂａトランスポーターの同定
JP2003531635A (ja) ヒト・ウィングレス（ｗｉｎｇｌｅｓｓ）様遺伝子
US6924357B2 (en) Lipid binding protein 4
JP2003531612A (ja) 新規ＧＴＰａｓｅ活性タンパク質１
JP2004500833A (ja) 新規脂質結合タンパク質３
JP2003531617A (ja) 新規セリン−トレオニン・キナーゼ
JP2003530122A (ja) 新規なセリン−トレオニンキナーゼ
JP2003532412A (ja) 新規セリン−トレオニン・キナーゼ−４
JP2004506422A (ja) 新規マイトジェン活性化キナーゼ
JP2004503242A (ja) スクランブラーゼ２
JP2004500834A (ja) 新規脂質結合タンパク質２
JP2004504841A (ja) アポトーシスタンパク質の新規タンパク質性阻害剤
US20050058647A1 (en) Phosphodiesterase type 7b
JP2003531619A (ja) ｃＡＭＰホスホジエステラーゼ７型（ＰＤＥ７ａ３）のスプライス変異体
JP2004506442A (ja) ＣａＭ−キナーゼＩＩ阻害剤の同定
JP2004508013A (ja) 新規セリン−トレオニン・キナーゼ−３
US20050107592A1 (en) Lipid binding protein 1
JP2004511252A (ja) ニューロメディンｕデルタ
JP2003528629A (ja) 新規なカルシウム結合調節サブユニット
JP2004532627A (ja) ２４０ｋＤにおけるヒスチジン・フォスファターゼ相互作用タンパク質
JP2004504830A (ja) 新規グルタミン輸送体の同定
JP2005507631A (ja) 新規ヒトｎ末端アセチルトランスフェラーゼの同定
JP2004508032A (ja) アポトーシスタンパク質の阻害剤の新規ファミリーメンバー